ALG13 UDP-N-acetylglucosaminyltransferase subunit activators encompass a range of small molecules that enhance its enzymatic activity, particularly in the context of protein glycosylation. These activators include compounds that directly supply substrates for the glycosylation process, such as nucleotide sugars that ALG13 utilizes to transfer N-acetylglucosamine to nascent glycoproteins. The process is further optimized by the presence of essential metal cofactors, which are integral for the catalytic activity of this enzyme, thus by increasing the availability of these cofactors, the efficiency and functional activity of ALG13 can be significantly improved. Additional compounds exert their activating influence by modulating secondary cellular processes which, in turn, enhance the glycosylation capacity of the cell, thereby indirectly promoting the function of ALG13. For instance, molecules that disrupt normal Golgi apparatus function may induce compensatory mechanisms that result in upregulated glycosyltransferase activities, including those mediated by ALG13.
Moreover, certain activators work by augmenting the pool of high-energy molecules and cofactors that are necessary for the multitude of enzymatic reactions taking place within the glycosylation pathway. These include, but are not limited to, donors of high-energy phosphate bonds and reducing equivalents, which are essential for the synthesis of glycoconjugates. The increased availability of these biochemical constituents can result in a more robust glycosylation environment, conducive to the activity of glycosyltransferases such as ALG13. Furthermore, some activators may lead to an upregulated ALG13 activity by triggering cellular stress responses to perturbations in the glycosylation machinery, thereby eliciting a cellular adaptation aimed at restoring homeostasis.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Activates adenylyl cyclase, increasing cAMP levels. Elevated cAMP enhances protein glycosylation, supporting ALG13 function. | ||||||
Uridine-5′-diphosphoglucose, disodium salt | 117756-22-6 | sc-296687 sc-296687A sc-296687B sc-296687C sc-296687D sc-296687E | 100 mg 1 g 10 g 50 g 100 g 1 kg | $99.00 $458.00 $2611.00 $13015.00 $16657.00 $41106.00 | 1 | |
Serves as a glucosyl donor for glycosyltransferases, directly fueling the glycosylation process where ALG13 is involved. | ||||||
Manganese(II) chloride beads | 7773-01-5 | sc-252989 sc-252989A | 100 g 500 g | $19.00 $31.00 | ||
Required as a cofactor for glycosyltransferases, thus optimizing the enzymatic function of ALG13. | ||||||
Brefeldin A | 20350-15-6 | sc-200861C sc-200861 sc-200861A sc-200861B | 1 mg 5 mg 25 mg 100 mg | $31.00 $53.00 $124.00 $374.00 | 25 | |
Disrupts Golgi structure, inducing a compensatory response that can enhance glycosyltransferase activities including ALG13. | ||||||
β-Nicotinamide adenine dinucleotide phosphate | 53-59-8 | sc-215560 sc-215560A | 100 mg 250 mg | $182.00 $319.00 | ||
Participates in biosynthetic reactions, providing reducing power that can indirectly support ALG13 enzymatic activity. | ||||||
D-Glucosamine | 3416-24-8 | sc-278917A sc-278917 | 1 g 10 g | $201.00 $779.00 | ||
Provides substrate for the hexosamine biosynthetic pathway, indirectly enhancing glycosyltransferase activity of ALG13. | ||||||
Magnesium chloride | 7786-30-3 | sc-255260C sc-255260B sc-255260 sc-255260A | 10 g 25 g 100 g 500 g | $28.00 $35.00 $48.00 $125.00 | 2 | |
Acts as an essential cofactor for many enzymes including glycosyltransferases, potentially enhancing ALG13 activity. | ||||||
Tunicamycin | 11089-65-9 | sc-3506A sc-3506 | 5 mg 10 mg | $172.00 $305.00 | 66 | |
Inhibits N-linked glycosylation, leading to compensatory cellular responses that may upregulate ALG13 activity. | ||||||